# 3. First-Line ASM Selection by Seizure Type

[← Previous: Classification](02-seizure-classification.md) | [Back to Main](../README.md) | [Next: Special Populations →](04-special-populations.md)

---

## 3.1 Focal Seizures (Adults)

| Evidence Level | Medication | Notes |
|----------------|------------|-------|
| **Level B** (Should consider) | **Lamotrigine** | SANAD II supports as first-line; good tolerability |
| **Level C** (May consider) | **Levetiracetam** | Rapid titration possible; watch for psychiatric effects |
| **Level C** (May consider) | **Zonisamide** | Weight-neutral; once-daily dosing |
| Alternative | Oxcarbazepine | Less enzyme induction than carbamazepine |
| Alternative | Eslicarbazepine | Once-daily dosing; similar to OXC; HLA-B*15:02 screening |
| Alternative | Carbamazepine | Effective but enzyme inducer |
| Alternative | Lacosamide | Good tolerability; cardiac monitoring needed |

> **SANAD II Trial Key Finding:** Lamotrigine demonstrated superiority to levetiracetam for time to treatment failure in focal epilepsy.

---

## 3.2 Focal Seizures (Elderly ≥60 years)

| Evidence Level | Medication | Notes |
|----------------|------------|-------|
| **Level B** | **Lamotrigine** | Preferred; minimal drug interactions |
| **Level C** | **Gabapentin** | No hepatic metabolism; renal dosing needed |
| Preferred | **Levetiracetam** | Minimal interactions; dose reduce for renal function |
| Alternative | Lacosamide | Good tolerability; avoid in cardiac conduction issues |

### ⚠️ Avoid in Elderly

- **Phenytoin** - cognitive effects, drug interactions, narrow therapeutic window
- **Phenobarbital** - sedation, cognitive impairment
- **Carbamazepine** - hyponatremia risk, enzyme induction

---

## 3.3 Focal Seizures (Pediatric)

| Age Group | First-Line | Second-Line |
|-----------|------------|-------------|
| **Infants (<1 year)** | Levetiracetam | Phenobarbital, Oxcarbazepine |
| **Children (1-12 years)** | Oxcarbazepine, Levetiracetam | Lamotrigine, Carbamazepine |
| **Adolescents (12-18 years)** | Lamotrigine, Levetiracetam | Oxcarbazepine, Eslicarbazepine, Lacosamide |

---

## 3.4 Generalized Tonic-Clonic Seizures

| Population | First-Line | Notes |
|------------|------------|-------|
| **Males** | Valproate | Most effective for GTC |
| **Females of childbearing potential** | Levetiracetam, Lamotrigine | Avoid valproate |
| **Elderly** | Levetiracetam, Lamotrigine | Avoid valproate (tremor, weight) |
| **Pediatric** | Valproate, Levetiracetam | Consider syndrome |

---

## 3.5 Absence Seizures

| Syndrome | First-Line | Second-Line | Avoid |
|----------|------------|-------------|-------|
| **Childhood Absence Epilepsy** | Ethosuximide*, Valproate* | Lamotrigine | Carbamazepine, Oxcarbazepine, Phenytoin, Gabapentin, Pregabalin, Vigabatrin |
| **Juvenile Absence Epilepsy** | Valproate, Lamotrigine | Levetiracetam | Same as above |

*Level B evidence: Ethosuximide or valproate should be considered before lamotrigine for CAE

---

## 3.6 Myoclonic Seizures

| First-Line | Second-Line | Avoid (May Exacerbate) |
|------------|-------------|------------------------|
| Valproate | Levetiracetam | Carbamazepine |
| Levetiracetam | Clonazepam | Oxcarbazepine |
| | Zonisamide | Phenytoin |
| | Topiramate | Gabapentin |
| | | Pregabalin |
| | | Vigabatrin |

> ⚠️ **Note:** Lamotrigine may occasionally exacerbate myoclonic seizures (NICE NG217)

---

## 3.7 Tonic and Atonic Seizures

| First-Line (Level C) | Adjunctive Options |
|---------------------|-------------------|
| Lamotrigine | Rufinamide (Lennox-Gastaut) |
| Valproate | Clobazam |
| | Felbamate (with caution) |
| | Cannabidiol |

---

## 3.8 Unknown Onset Seizures

When seizure type cannot be determined:

| Situation | Recommended ASM |
|-----------|-----------------|
| **Likely focal** | Lamotrigine, Levetiracetam |
| **Likely generalized** | Valproate (males), Levetiracetam (females) |
| **Truly unknown** | Levetiracetam, Valproate, Lamotrigine |

---

## 3.9 Quick Reference Summary

| Seizure Type | First Choice | Alternatives | Avoid |
|--------------|--------------|--------------|-------|
| **Focal** | Lamotrigine, Levetiracetam | OXC, ESL, CBZ, LCM, ZNS | - |
| **Focal (elderly)** | Lamotrigine, Levetiracetam, Gabapentin | Lacosamide | PHT, PB, CBZ |
| **GTC** | Valproate (males), LEV/LTG (females) | TPM, ZNS, PER | - |
| **Absence** | Ethosuximide, Valproate | Lamotrigine | CBZ, GBP, PHT, OXC |
| **Myoclonic** | Valproate, Levetiracetam | ZNS, TPM, CLB | CBZ, GBP, PHT, OXC, LTG* |
| **Tonic/Atonic** | Lamotrigine, Valproate | Rufinamide, Clobazam | - |

*LTG may exacerbate myoclonic seizures in some patients

---

[← Previous: Classification](02-seizure-classification.md) | [Back to Main](../README.md) | [Next: Special Populations →](04-special-populations.md)
